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Delirium is a neuropsychiatric syndrome that is frequently encountered by older hospitalized 
adults. Although considered a reversible condition, it is independently associated with important 
negative outcomes such as a greater risk of institutionalization, dementia, and death. Many 
delirium episodes that occur in the hospital setting concern surgery patients that experience 
delirium in the perioperative period. The incidence of perioperative delirium is likely to increase 
with the aging population and evolving diagnostic and therapeutic procedures that are currently 
becoming available for a larger number of older patients. 
How delirium can result in permanent functional and cognitive impairment in some older 
patients, is incompletely understood. Also, clinicians who take care of older surgery patients, are 
often faced with clinical dilemma’s concerning the performance of interventions that might 
prevent or evoke delirium. Lastly, selecting patients on forehand who will improve from surgery 
on outcomes that are most relevant to older patients like functional independency and quality of 
life, remains a challenge. Further studying these patient-centered outcomes could improve this 
process. The aim of this thesis was to shed light on relations observed between perioperative 
delirium and cognitive and functional decline, in order to improve care and outcomes for older 
surgery patients.  
Part 1: Studies on factors that show a temporal relation with the development of 
delirium in the perioperative period 
In this part we investigated two events that might show a temporal relation with the onset of 
delirium. We explored the hypothesis that acute irreversible brain damage occurs during an 
episode of delirium, as an explanation of the association between delirium and subsequent 
development of cognitive decline. We did so by studying a well-established biomarker of acute 
brain cell damage, S100B. Next, we investigated whether a blood transfusion can serve as a 
protecting or precipitating factor for delirium in hip fracture patients with anemia in the 
postoperative period. 
In chapter 2 we measured the level of S100B in cerebrospinal fluid (CSF) in a sample of hip 
fracture patients with and without perioperative delirium, who received surgical repair that was 
performed under spinal anaesthesia. We found no difference in S100B levels between groups. 
We did find that two patients that were already delirious at the time the CSF sample was taken, 
had relatively high S100B levels compared to patients who developed delirium after the sample 
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was taken and compared to patients that did not develop delirium at all. From this we learned 
that timing of S100B measurement in relation to the onset of delirium seems of major 
importance when studying the position of this biomarker in research on delirium 
pathophysiology. 
In chapter 3 we studied S100B in repeated serum samples in a different cohort of hip fracture 
patients, and the association of S100B level with delirium and cognitive decline after 12 months. 
We hypothesized that if S100B would be a biomarker of acute brain damage related to delirium, 
this might reflect in long term irreversible cognitive decline or death. By using repeated S100B 
measurements we sought to better capture a possible rise in S100B level before, during or after 
delirium. In this cohort premorbid cognitive impairment was present in 58.7% of patients and 
33.0% experienced delirium. Delirium was not associated with higher S100B levels before, 
during or after delirium, after controlling for important confounders. We found that S100B levels 
were more often increased in older age, in the presence of an intercurrent infection, and after 
surgery as compared to levels before surgery. Cognitive decline or death were more often 
experienced by patients with perioperative delirium than by patients without delirium (58.6% 
versus 36.5%). To our surprise, higher S100B levels were associated with this outcome only in 
patients without delirium. A possible explanation is that enough brain tissue might need to be 
preserved to be able to shed S100B from astrocytes that are damaged. Patients with delirium 
more often had (advanced) cognitive impairment, and they might have less brain tissue ‘to lose’. 
Based on these results, we were not able to either reject nor confirm the hypothesis of acute brain 
damage occurring during delirium. 
In chapter 4 and 5 we sought to resolve a clinical dilemma: whether or not to administer a blood 
transfusion to a post-surgery patient with moderate anemia, but no strict indication for 
transfusion when following current guidelines. In this scenario blood transfusion could be 
regarded as a measure to prevent delirium, as it resolves anemia which is a precipitating factor of 
delirium. On the other hand, transfusion in itself could serve as a precipitating factor due to fact 
that it is a medical procedure that can result in discomfort, complications and possibly a systemic 
inflammatory response. In chapter 4 we provided a systematic literature overview of studies on 
blood transfusion as a risk factor or protective factor for delirium. We included 23 studies, of 
whom 21 were observational studies addressing the association of several factors with delirium 
occurrence, and two were randomized controlled trials (RCT’s) investigating different 
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transfusion strategies and delirium. Quality of the included studies was limited in 22 studies and 
uncertain in one. Timing of delirium onset with respect to transfusion was a concern, this was 
only properly addressed in four studies. In one of these studies, it was found that a blood 
transfusion of >1000 mililiter during surgery was a risk factor for postoperative delirium. In the 
other three studies no association between transfusion and delirium was found. No proper 
conclusion could be drawn from the studies that did not describe whether delirium occurred 
before or after transfusion. Taking this all into consideration, we were not able to solve our 
clinical dilemma by studying the existing literature. 
Therefore, in chapter 5, we used our cohort of hip fracture patients, also studied in chapter 3 and 
4, to investigate the association of anemia with delirium, and the role of blood transfusion within 
the multicomponent prevention strategy of delirium. We found that having anemia (hemoglobin 
level <6mmol/L) at any point during hospitalization was associated with increased odds of 
experiencing delirium (odds ratio 1.81; 95% confidence interval 1.15-2.86). We next selected a 
subgroup of patients who had anemia at some point during hospitalization and excluded all 
patients with delirium onset before administration of transfusion. In this subgroup we found that 
blood transfusion had an odds ratio of 0.26 (95% confidence interval 0.10-0.70) for development 
of delirium, which suggest that transfusion might be regarded as a protective factor for delirium 
in patients with anemia after hip fracture surgery. A limitation of this study was that it was not 
primary designed to answer our research question, and as the decision to administer a blood 
transfusion was made by the attending physician, it might be based on factors that not have been 
accounted for in our analysis. 
Part 2: Studies on delirium and its effects on long term functional and cognitive 
outcome  
In part 2 of this thesis, we studied cognitive and functional perfomance of older patients 
undergoing acute or elective surgery during the first year after the procedure. 
In chapter 6 we described patterns of cognitive change in the first 12 months after surgery in a 
cohort of hip fracture patients. We were interested in different patterns of improvement and 
decline that can be seen when no assumptions are made on which predefined subgroups might 
perform better or worse. We applied an established statistical technique called Group Based 
Trajectory Modelling (GBTM), using the Mini Mental State Examination (MMSE) as 
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measurement of cognitive functioning. In the first year after hip fracture, we identified the 
following three cognitive trajectories: improvement (57.9%), stable (28.1%), and rapid decline 
(13.9%), with an annual MMSE change of 1.7, 0.8, and -3.5 points respectively. These three 
groups also showed a clearly distinct clinical phenotype, with age, levels of premorbid cognitive 
and functional impairment and perioperative delirium rising across worsening trajectory groups. 
This could be useful information when informing patients and caregivers on possible surgery 
outcomes, and organizing post hospital care.  
Lastly, in chapter 7, we studied a cohort of patients undergoing transcatheter aortic valve 
implantation (TAVI). In this specific population it is known that a proportion of patients does not 
benefit from the procedure in terms of functional recovery and quality of life. We wanted to 
explore the role of perioperative delirium as a cause of these negative outcomes. We found that 
in our cohort the incidence of delirium was 15.4%, and that 38.5% experienced functional 
decline and 11.0% of patients died during a mean follow up time of seven months. Postoperative 
delirium resulted in increased odds for the combined outcome functional decline or death. 
Patients with functional decline reported a lower quality of life than patients with a stable or 
improved functional status at follow up. These results emphasis that this risk should be 
incorporated in the process of shared decision making and delirium prevention should remain a 
top priority in TAVI patients. 
